With more than 70 members the Sealy Institute for Vaccine Sciences (SIVS) incorporates the expertise of more than 100 cutting-edge research programs. The faculty and staff of the SIVS strive to generate, perfect, and promote the most effective and safest disease prevention strategies.
See full profile
In this effort, the Institute carries on the proud tradition of medical research and discovery that has been a hallmark of the University of Texas Medical Branch (UTMB) since its inception.
The SIVS combines the expertise of basic scientists in many areas, including virologists, bacteriologists, parasitologists, materials scientists and immunologists, and physician-scientists who undertake clinical research and regulatory scientists with experience necessary to prepare a candidate vaccine for progression into the testing and evaluation pipeline.
As one of the most comprehensive university-based vaccine development centers in the US, the SIVS participates in four out of the five components (excluding manufacturing) of the vaccine development pathway:
- Basic & Discovery Research
- Vaccines for infectious diseases, including chronic diseases
- Biothreat agents, BSL2-BSL4
- Pre/Nonclinical Development
- Animal models of infectious diseases
- Regulated studies and quality systems
- Clinical Research and Trials
- Phase I-IV vaccine clinical trials
- Federal and Pharma studies
- Policy and vaccine acceptance research
- Public and healthcare provider education
Visit website: www.utmb.edu/sivs
Sanofi Pasteur is the vaccines division of Sanofi. Our vision is a world in which no one suffers or dies from a vaccine preventable disease. Our mission is to protect and improve human health worldwide by providing superior, innovative vaccines for the prevention and treatment of disease and by playing an active role in the immunization community to maximize vaccination.
See full profile
Sanofi Pasteur is the largest company in the world devoted entirely to human vaccines. We distribute more than 1 billion doses of vaccine per year, making it possible to vaccinate more than 500 million people across the globe.
Our vaccines protect against 20 infectious diseases: cholera, diphtheria, Haemophilus influenzae type b infections, hepatitis A, hepatitis B, influenza, Japanese encephalitis, measles, meningococcal infections, mumps, pertussis, pneumococcal infections, poliomyelitis, rabies, rubella, smallpox, tetanus, tuberculosis, typhoid fever, yellow fever.
Sanofi Pasteur is the world’s largest producer of seasonal influenza vaccine (more than 200 million doses in 2013) and the world’s leading provider of inactivated poliomyelitis vaccine.
Visit website: www.sanofipasteur.com